Bronx, NY (PRWEB) August 14, 2014
Dr. Emil J. Haldey, president of New York City-based HALDEY Pharmaceutical Compounding, will speak this week before an audience of resident podiatric physicians at The Podiatric Residency Education Summit.
The event will take place on Friday, Aug 15, from 9:30 to 10 a.m., in Teaneck Marriott, 100 Frank W Burr Blvd, Teaneck, NJ.
Dr. Haldey, a doctor of pharmacy, will discuss the history, rationale and benefits of prescription-drug compounding for modern medical and podiatry practices. His talk will cover common pathologies, clinical case studies and customized-therapy considerations in various fields of medicine, such as pain management, dermatology, podiatry, etc. Special attention will be given to common pathologies seen in the podiatric practice, such as neuropathic and other pain conditions, plantar fasciitis, warts, and more.
About HALDEY Pharmaceutical Compounding
New York City-based HALDEY Pharmaceutical Compounding, as its name implies, specializes in pharmaceutical compounding. The enterprise focuses solely on tailoring prescriptions to meet the specific needs of each individual patient, including those dealing with unique medical circumstances.
HALDEY Pharmaceutical Compounding’s innovative scientific solutions embrace a host of medical and quality-of-life issues, such as pain management; anti-aging and integrative medicine; holistic health; hospice care; dermatology, and health and wellness, to name just a few.
For additional information, HALDEY Pharmaceutical Compounding may be reached at 855-H-COMPOUND (855-426-6768), or via the company’s Website: http://www.hcompound.com.
The Podiatric Residency Education Summit (ResEdSummit.com) was developed in by PRESENT e-Learning Systems to provide a specialty education format specifically for Podiatric Residents, Residency Directors and Attendings. The organization may be reached at 888-802-8410.